newsfilter
← Latest News
ACCESS Newswire·

Novamind to Participate in Citi's Psychedelic Drug Video Call Series

TORONTO, ON / ACCESSWIRE / January 20, 2022 / Novamind Inc. (CSE:NM)(OTCQB:NVMDF)(FSE:HN2) ("Novamind" or the "Company"), a leading mental health company specialized in psychedelic medicine, announced today that it will participate in Citi's Psychedelic